Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Tougeron

Showing results (71-80 of 235) with videos related to

Pageof 24
Sort By:
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2018
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)Aziz Zaanan, Emmanuelle Samalin, Thomas Aparicio, et al.
Cancers|January 21, 2022
Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal CancerQuang Loc Bui, Léo Mas, Antoine Hollebecque, et al.
Journal of the National Cancer Institute|May 17, 2020
Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial OriginAziz Zaanan, Julie Henriques, Romain Cohen, et al.
BMC Cancer|April 10, 2013
Genetic variations of the A13/A14 repeat located within the EGFR 3' untranslated region have no oncogenic effect in patients with colorectal cancerNasrin Sarafan-Vasseur, David Sefrioui, David Tougeron, et al.
BMC Cancer|November 29, 2025
Real-world efficacy of nanoliposomal irinotecan in patients with advanced pancreatic cancerMarie Decraecker, Sophie Le Joncour, Valérie Aurillac, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 20, 2020
Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)David Tougeron, Pierre Michel, Astrid Lièvre, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 23, 2025
Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 - PRODIGE 84 phase II trial (PREMICES)Jérémie H Lefevre, Olivier Dubreuil, Raphael Colle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancerIsabelle Iwanicki-Caron, Frédéric Di Fiore, Isabelle Roque, et al.
Medicine|October 27, 2015
Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues OncologuesBertrand Brieau, Céline Lepère, Thomas Walter, et al.
Clinical Colorectal Cancer|October 26, 2019
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter StudyMarie Auvray, David Tougeron, Edouard Auclin, et al.
Pageof 24

Showing results (71-80 of 235) with videos related to

Sort By:
Pageof 24
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 8, 2018
Phase III randomized trial comparing 5-fluorouracil and oxaliplatin with or without docetaxel in first-line advanced gastric cancer chemotherapy (GASTFOX study)Aziz Zaanan, Emmanuelle Samalin, Thomas Aparicio, et al.
Cancers|January 21, 2022
Treatments after Immune Checkpoint Inhibitors in Patients with dMMR/MSI Metastatic Colorectal CancerQuang Loc Bui, Léo Mas, Antoine Hollebecque, et al.
Journal of the National Cancer Institute|May 17, 2020
Efficacy of Anti-EGFR in Microsatellite Instability Metastatic Colorectal Cancer Depending on Sporadic or Familial OriginAziz Zaanan, Julie Henriques, Romain Cohen, et al.
BMC Cancer|April 10, 2013
Genetic variations of the A13/A14 repeat located within the EGFR 3' untranslated region have no oncogenic effect in patients with colorectal cancerNasrin Sarafan-Vasseur, David Sefrioui, David Tougeron, et al.
BMC Cancer|November 29, 2025
Real-world efficacy of nanoliposomal irinotecan in patients with advanced pancreatic cancerMarie Decraecker, Sophie Le Joncour, Valérie Aurillac, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 20, 2020
Management of digestive cancers during the COVID-19 second wave: A French intergroup point of view (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR)David Tougeron, Pierre Michel, Astrid Lièvre, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|November 23, 2025
Neoadjuvant pembrolizumab with a watch‑and‑wait strategy for localized MSI/dMMR colon cancer: Study protocol for a randomized GERCOR 109 - PRODIGE 84 phase II trial (PREMICES)Jérémie H Lefevre, Olivier Dubreuil, Raphael Colle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2008
Usefulness of the serum carcinoembryonic antigen kinetic for chemotherapy monitoring in patients with unresectable metastasis of colorectal cancerIsabelle Iwanicki-Caron, Frédéric Di Fiore, Isabelle Roque, et al.
Medicine|October 27, 2015
Radiochemotherapy Versus Surgery in Nonmetastatic Anorectal Neuroendocrine Carcinoma: A Multicenter Study by the Association des Gastro-Entérologues OncologuesBertrand Brieau, Céline Lepère, Thomas Walter, et al.
Clinical Colorectal Cancer|October 26, 2019
Efficacy and Safety of Aflibercept in Combination With Chemotherapy Beyond Second-Line Therapy in Metastatic Colorectal Carcinoma Patients: An AGEO Multicenter StudyMarie Auvray, David Tougeron, Edouard Auclin, et al.
Pageof 24